Tumor Circadian Clock Strength Influences Metastatic Potential and Predicts Patient Prognosis in Luminal a Breast Cancer

Scientists reconstructed rhythms informatically, integrating locally collected, time-stamped biopsies with public datasets. For noncancerous breast tissue, inflammatory, epithelial–mesenchymal transition, and estrogen responsiveness pathways show circadian modulation.